ClinicalTrials.Veeva

Menu

Pediatric Cohort Study (COSACM)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Unknown

Conditions

Narcolepsy in Children

Treatments

Other: Study of Sleep architecture in children with narcolepsy

Study type

Observational

Funder types

Other

Identifiers

NCT04561427
COSACM_2020

Details and patient eligibility

About

Narcolepsy is a rare disease that affects 0.05% of the general population. It is characterized by a dysregulation of the sleep wake regulation that leads to uncontrolled sleep episode during day and a disorganized sleep during night. These symptoms are due to a loss of hypocretin neurons in the brain leading to an inability to maintain wake properly. The physiopathology of this rare disease still needs investigations. Since we are a reference center for this disease, we propose to use patients files to better describe and document the sleep characteristics of these children, the cognitive performances, the effects of narcolepsy treatments on sleep architecture and the metabolic status of these children.

Enrollment

120 estimated patients

Sex

All

Ages

Under 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients between 0 and 18 years old
  • Patients diagnosed with primary or secondary narcolepsy
  • From both gender

Exclusion criteria

  • Patients diagnosed with another sleep disorder
  • Healthy patients
  • Patients older than 18 years old

Trial design

120 participants in 1 patient group

Pediatric Patients with narcolepsy
Description:
* Patients between 0 and 18 years old * Patients diagnosed with primary or secondary narcolepsy * From both gender
Treatment:
Other: Study of Sleep architecture in children with narcolepsy

Trial contacts and locations

1

Loading...

Central trial contact

Patricia Franco; Aurore Guyon

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems